Menu
Recruiting NCT05024981

Videographic Feedback and Walk Rehabilitation in Post-Cerebrovascular Accident

No phase Interventional Cerebrovascular Accident

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Videographic feedback, Classic reeducation.
Who it may be relevant to
Registry conditions: Cerebrovascular Accident. Basic parameters: from 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Cerebrovascular Accident affects the majority of the elderly population and its frequency is constantly increasing. The resulting deficits are numerous and lead in particular to an alteration in the quality of walking and autonomy. Numerous rehabilitation techniques have been described. In practice, correction instructions are often given by the therapist while the motor activity is being performed. Walking is a complex activity, as is the processing of dual-task information in elderly stroke patients. It therefore appears interesting to separate the time of motor realization and that of correction instructions. Investigators therefore propose firstly to film the patient during the performance of a walking activity and then, secondly, to analyse the video with the patient, which thus represents a source of delayed feedback. The main objective of the study is to observe the effects of this practice on walking speed. Investigators are comparing two groups of patients: the control group receiving conventional rehabilitation and the experimental group receiving conventional rehabilitation plus sessions with the video tool. They expect to observe a greater improvement in walking speed in the experimental group.

Interventions

  • Behavioral Videographic feedback
    Twice a week during his classic re-education sessions, the patient will be filmed for 1 minute. After transferring the video to a tablet, he will watch the video once and decide what he wants to correct. During the second viewing, he will analyse his walk, the therapist being present to provide additional information. Finally, the patient will apply his analysis while being filmed and will compare the possible differences between the 2 videos. Depending on the time available, the patient may hav
  • Behavioral Classic reeducation
    The patient will benefit twice a day for 30 minutes from re-education sessions.

Primary outcome measures

  • Walking speed [Time frame: Day 26]

Eligibility criteria

Inclusion criteria

  • Hospitalization for a first episode of Cerebrovascular Accident less than six months old, or nth stroke less than six months old, with no previous sequelae;
  • Able to walk at least 10m without stopping, with or without technical assistance, but without human assistance, under supervision;

Exclusion criteria

  • Palliative or life-threatening situation;
  • A patient whose guardian or trustee is not readily available to provide information about the patient
  • Neuro-cognitive disorder that prevents understanding of instructions, as determined by the clinician;
  • Severe speech or language disorder that prevents the protocol from being carried out correctly;
  • Hemineglect;
  • Any previously known pathology altering the gait pattern, at the clinician's discretion (recent neurological, traumatological or orthopaedic pathologies, etc.);
  • Visual disorder preventing viewing of the video;
  • Hearing disorder preventing comprehension.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

France · 1 center
  • CHU Nice — Nice

Identifiers

NCT: NCT05024981 · 19-GIRCI-02

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗